Efficacy and safety of the farnesoid X receptor agonist obeticholic acid in patients with type 2 diabetes and nonalcoholic fatty liver disease (Q34347996)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and safety of the farnesoid X receptor agonist obeticholic acid in patients with type 2 diabetes and nonalcoholic fatty liver disease |
scientific article |
Statements
1 reference
Efficacy and safety of the farnesoid X receptor agonist obeticholic acid in patients with type 2 diabetes and nonalcoholic fatty liver disease (English)
1 reference
Sunder Mudaliar
1 reference
Robert R Henry
1 reference
Arun J Sanyal
1 reference
Linda Morrow
1 reference
Hanns-Ulrich Marschall
1 reference
Mark Kipnes
1 reference
Luciano Adorini
1 reference
Cathi I Sciacca
1 reference
Paul Clopton
1 reference
Erin Castelloe
1 reference
Paul Dillon
1 reference
Mark Pruzanski
1 reference
David Shapiro
1 reference
1 reference
Identifiers
1 reference